Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3482-3486

  Lounis, N ^a   Bentoucha, A ^a   Trufoot Pernot, C ^a   Ji, B ^a   O'Brein, R J ^a   Vernon, A ^a   Roscigno, G ^a   Grosset, J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; RIFAPENTINE; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; FOLLOW UP; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; AZA COMPOUNDS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MICROBIAL; FEMALE; FLUOROQUINOLONES; ISONIAZID; LUNG; MICE; MYCOBACTERIUM TUBERCULOSIS; ORGAN SIZE; QUINOLINES; RIFAMPIN; SPLEEN; STREPTOMYCIN; SURVIVAL RATE; TUBERCULOSIS;

EID: 0035191458     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3482-3486.2001     Document Type: Article

References (21)

1. Mesure de la sensibilité du bacille tuberculeux aux drogues antibacillaires par la méthode des proportions. Methodologie, critères de résistance, résultats, interprétation
2. Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice
3. Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens
4. Statistics in practice. Comparing the mean of several groups
5. Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice
6. Late results of long-term intermittent chemotherapy of advanced murine tuberculosis. Limits of the murine model
7. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice
8. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis
9. Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice
10. Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?
11. Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation
12. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis
13. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: A comparison in humans and other mammalian species
14. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man
15. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis: Initial report
16. Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone